Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0600
0.00 (0.00%)
Sep 17, 2026, 2:55 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 32.59 million as of September 17, 2026. Its market cap has increased by 225.31% in one year.
Market Cap
32.59M
Enterprise Value
31.05M
Revenue
4.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 32.59M, a decrease of -66.86%. That is a compound annual growth rate of -17.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 32.59M | 32.38% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Epiminder | 61.75M |
| Cyclopharm | 60.35M |
| Compumedics | 46.94M |
| HeraMED | 45.19M |
| Cleo Diagnostics | 43.19M |
| Nova Eye Medical | 38.46M |
| OncoSil Medical | 35.79M |
| CleanSpace Holdings | 28.97M |